The evolving role of ankyrin-B in cardiovascular disease

Sara N Koenig1, Peter J Mohler1

  • 1Dorothy M. Davis Heart & Lung Research Institute, Department of Physiology and Cell Biology, The Ohio State University College of Medicine, Wexner Medical Center, Columbus, Ohio.

Heart Rhythm
|August 3, 2017
PubMed

Insights

Ankyrin-B is crucial for heart function, regulating proteins for excitability and integrity. ANK2 gene variants cause "ankyrin-B syndrome," leading to various heart rhythm disorders.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Ankyrin-B plays a key role in cardiac physiology, influencing protein expression, localization, and regulation.
  • It is essential for maintaining cardiac excitability, cytoskeletal integrity, and signaling pathways.
  • Human ANK2 variants causing ankyrin-B loss-of-function are linked to "ankyrin-B syndrome."

Purpose of the Study:

  • To review the known functions of ankyrin-B in the heart.
  • To summarize the impact of ankyrin-B dysfunction in cardiac disease models and humans.
  • To highlight recent findings on the complexity of ankyrin-B signaling.

Main Methods:

  • Literature review of ankyrin-B research.
  • Analysis of animal models with ankyrin-B dysfunction.
  • Examination of human genetic data and clinical phenotypes associated with ANK2 variants.

Main Results:

  • Ankyrin-B regulates critical proteins involved in cardiac ion channel function and stability.
  • Ankyrin-B syndrome presents with a spectrum of arrhythmias, including bradycardia, conduction block, and ventricular tachycardia.
  • Complexities in gene regulation and associated molecules contribute to diverse clinical presentations.

Conclusions:

  • Ankyrin-B is vital for normal cardiac function and its dysfunction leads to significant arrhythmias.
  • Further research is needed to fully elucidate the molecular mechanisms of ankyrin-B in cardiac health and disease.
  • Understanding ankyrin-B signaling is crucial for diagnosing and potentially treating "ankyrin-B syndrome."

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
478
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
555
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
805
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
4.4K